{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:51:51Z","timestamp":1790887911608,"version":"4.1.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:00:00Z","timestamp":1689292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Chronic lymphocytic leukemia\/small lymphocytic lymphoma (CLL\/SLL) is the most common leukemia in adults in Western countries. Transformation of CLL\/SLL to plasmablastic lymphoma (PBL) is exceedingly rare and often has an extremely poor response to treatment. A thorough molecular workup may help in determining clonality-relatedness and prognosis. We describe two cases of CLL\/SLL that transformed into PBL, with an extensive molecular workup in one case, and a review of the literature.<\/jats:p>","DOI":"10.1093\/labmed\/lmad060","type":"journal-article","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T16:11:19Z","timestamp":1689351079000},"page":"e177-e185","source":"Crossref","is-referenced-by-count":4,"title":["Plasmablastic transformation of chronic lymphocytic leukemia: a review of literature and report on 2 cases"],"prefix":"10.1093","volume":"54","author":[{"given":"Anurag","family":"Khanna","sequence":"first","affiliation":[{"name":"Emory University School of Medicine, Department of Pathology and Laboratory Medicine , Atlanta, GA , US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley R","family":"Drumheller","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine, Department of Pathology and Laboratory Medicine , Atlanta, GA , US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Deeb","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine, Department of Pathology and Laboratory Medicine , Atlanta, GA , US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan Wade","family":"Tolbert","sequence":"additional","affiliation":[{"name":"NHCI Georgia Cancer Specialist 2 , Atlanta, GA , US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0037-2707","authenticated-orcid":false,"given":"Saja","family":"Asakrah","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine, Department of Pathology and Laboratory Medicine , Atlanta, GA , US"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,7,14]]},"reference":[{"key":"2023110721241376800_CIT0001","first-page":"216","article-title":"Chronic lymphocytic leukemia\/small lymphocytic lymphoma","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Campo","year":"2017"},{"issue":"15","key":"2023110721241376800_CIT0002","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1200\/JCO.2005.05.0187","article-title":"Clinical outcomes and prognostic factors in patients with Richter\u2019s syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation","volume":"24","author":"Tsimberidou","year":"2006","journal-title":"J Clin Oncol."},{"key":"2023110721241376800_CIT0003","first-page":"261","article-title":"B-cell chronic lymphocytic leukemia\/small lymphocytic lymphoma, monoclonal B-cell lymphocytosis, and B-cell prolymphocytic leukemia","volume-title":"Hematopathology","author":"Chabot-Richards","year":"2016"},{"issue":"12","key":"2023110721241376800_CIT0004","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1182\/blood-2010-09-302174","article-title":"The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation","volume":"117","author":"Rossi","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2023110721241376800_CIT0005","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000505683","article-title":"Chronic lymphocytic leukemia with divergent Richter\u2019s transformation into a clonally related classical Hodgkin\u2019s and plasmablastic lymphoma: a case report","volume":"13","author":"Gasljevic","year":"2020","journal-title":"Case Rep Oncol"},{"issue":"9","key":"2023110721241376800_CIT0006","doi-asserted-by":"crossref","first-page":"e235816","DOI":"10.1136\/bcr-2020-235816","article-title":"Transformation to plasmablastic lymphoma in CLL upon ibrutinib treatment","volume":"13","author":"Marvyin","year":"2020","journal-title":"BMJ Case Rep"},{"key":"2023110721241376800_CIT0007","first-page":"2861596","article-title":"Plasmablastic lymphoma with coexistence of chronic lymphocytic leukemia in an immunocompetent patient: a case report and mini-review","volume":"2017","author":"Hatzimichael","year":"2017","journal-title":"Case Rep Hematol"},{"issue":"6","key":"2023110721241376800_CIT0008","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1097\/PAI.0000000000000441","article-title":"Richter syndrome with plasmablastic lymphoma at primary diagnosis: a case report with a review of the literature","volume":"25","author":"Ronchi","year":"2017","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"2","key":"2023110721241376800_CIT0009","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/bjh.14062","article-title":"Plasmablastic Richter transformation as a resistance mechanism for chronic lymphocytic leukaemia treated with BCR signaling inhibitors","volume":"177","author":"Chan","year":"2017","journal-title":"Br J Haematol."},{"issue":"2","key":"2023110721241376800_CIT0010","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/bjh.13562","article-title":"Evolution to plasmablastic lymphoma evades CD19-directed chimeric antigen receptor T cells","volume":"171","author":"Evans","year":"2015","journal-title":"Br J Haematol."},{"issue":"10","key":"2023110721241376800_CIT0011","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.humpath.2013.04.008","article-title":"Plasmablastic transformation of low-grade CD5+ B-cell lymphoproliferative disorder with MYC gene rearrangements","volume":"44","author":"Pan","year":"2013","journal-title":"Hum Pathol."},{"issue":"2","key":"2023110721241376800_CIT0012","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/PAS.0b013e31826cb1d1","article-title":"Plasmablastic transformation of low-grade B-cell lymphomas: report on 6 cases","volume":"37","author":"Martinez","year":"2013","journal-title":"Am J Surg Pathol."},{"issue":"12","key":"2023110721241376800_CIT0013","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1200\/JCO.2012.46.9593","article-title":"Brentuximab vedotin demonstrates activity in a patient with plasmablastic lymphoma arising from a background of chronic lymphocytic leukemia","volume":"31","author":"Holderness","year":"2013","journal-title":"J Clin Oncol."},{"issue":"12","key":"2023110721241376800_CIT0014","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.humpath.2010.04.019","article-title":"Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia\/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus","volume":"41","author":"Foo","year":"2010","journal-title":"Hum Pathol."},{"issue":"10","key":"2023110721241376800_CIT0015","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1080\/10428190802251795","article-title":"Plasmablastic lymphoma with small lymphocytic lymphoma: clinicopathologic features, and review of the literature","volume":"49","author":"Ramalingam","year":"2008","journal-title":"Leuk Lymphoma"},{"issue":"5-6","key":"2023110721241376800_CIT0016","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1034\/j.1600-0609.2001.00592.x","article-title":"Plasmablastic lymphoma in a patient with chronic lymphocytic leukemia heavily pretreated with cladribine (2-CdA): an unusual variant of Richter\u2019s syndrome","volume":"67","author":"Robak","year":"2001","journal-title":"Eur J Haematol."},{"issue":"9","key":"2023110721241376800_CIT0017","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1002\/1097-0142(19841101)54:9<1904::AID-CNCR2820540921>3.0.CO;2-E","article-title":"Transformation of chronic lymphocytic leukemia to plasmacytoma","volume":"54","author":"Pines","year":"1984","journal-title":"Cancer."},{"issue":"1","key":"2023110721241376800_CIT0018","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/sj.leu.2403543","article-title":"Translocation t(1;6)(p35.3;p25.2): a new recurrent aberration in \u201cunmutated\u201d B-CLL","volume":"19","author":"Michaux","year":"2005","journal-title":"Leukemia."},{"key":"2023110721241376800_CIT0019","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.16_suppl.3074","article-title":"Development and validation of Duoseq as a novel diagnostic and companion assay for lymphoma and other cancers","volume-title":"American Society of Clinical Oncology.","author":"Rozzi","year":"2022"},{"issue":"2","key":"2023110721241376800_CIT0020","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/10428194.2011.608447","article-title":"Large B-cell lymphomas with plasmablastic differentiation: a biological and therapeutic challenge","volume":"53","author":"Montes-Moreno","year":"2012","journal-title":"Leuk Lymphoma."},{"key":"2023110721241376800_CIT0021","first-page":"241","article-title":"Plasma cell neoplasms","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"McKenna","year":"2017"},{"issue":"6","key":"2023110721241376800_CIT0022","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.3324\/haematol.2018.214056","article-title":"KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study","volume":"105","author":"Ferrero","year":"2020","journal-title":"Haematologica."},{"issue":"13","key":"2023110721241376800_CIT0023","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1182\/bloodadvances.2020001696","article-title":"Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma","volume":"4","author":"Rushton","year":"2020","journal-title":"Blood Adv."},{"issue":"7574","key":"2023110721241376800_CIT0024","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature15395","article-title":"Mutations driving CLL and their evolution in progression and relapse","volume":"526","author":"Landau","year":"2015","journal-title":"Nature."},{"issue":"10","key":"2023110721241376800_CIT0025","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/nm.3943","article-title":"The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development","volume":"21","author":"Ortega-Molina","year":"2015","journal-title":"Nat Med."},{"issue":"9","key":"2023110721241376800_CIT0026","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.3109\/10428194.2016.1173212","article-title":"Genetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targets","volume":"57","author":"Bogusz","year":"2016","journal-title":"Leuk Lymphoma."},{"issue":"38","key":"2023110721241376800_CIT0027","doi-asserted-by":"crossref","first-page":"62627","DOI":"10.18632\/oncotarget.11548","article-title":"Recurrent mutations in NF-\u03baB pathway components, KMT2D, and NOTCH1\/2 in ocular adnexal MALT-type marginal zone lymphomas","volume":"7","author":"Johansson","year":"2016","journal-title":"Oncotarget"},{"issue":"8","key":"2023110721241376800_CIT0028","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1038\/s41375-021-01124-5","article-title":"High incidence of MYD88 and KMT2D mutations in Chinese with chronic lymphocytic leukemia","volume":"35","author":"Yi","year":"2021","journal-title":"Leukemia."},{"issue":"3","key":"2023110721241376800_CIT0029","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/pin.13067","article-title":"B cell lymphoma with IRF4 rearrangement: a clinicopathological study of 13 cases","volume":"71","author":"Zhou","year":"2021","journal-title":"Pathol Int."},{"issue":"1","key":"2023110721241376800_CIT0030","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2141.2008.07152.x","article-title":"MYC translocation in chronic lymphocytic leukaemia is associated with increased prolymphocytes and a poor prognosis","volume":"142","author":"Huh","year":"2008","journal-title":"Br J Haematol."},{"issue":"6","key":"2023110721241376800_CIT0031","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00277-011-1393-y","article-title":"Chronic lymphocytic leukemia","volume":"91","author":"Put","year":"2012","journal-title":"Ann Hematol."},{"issue":"5","key":"2023110721241376800_CIT0032","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/modpathol.2016.35","article-title":"The clinical significance of 8q24\/MYC rearrangement in chronic lymphocytic leukemia","volume":"29","author":"Li","year":"2016","journal-title":"Mod Pathol."},{"issue":"1","key":"2023110721241376800_CIT0033","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1750-9378-5-22","article-title":"Epstein-Barr virus infection and chronic lymphocytic leukemia: a possible progression factor","volume":"5","author":"Dolcetti","year":"2010","journal-title":"Infect Agents Cancer"},{"issue":"10","key":"2023110721241376800_CIT0034","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1038\/leu.2012.246","article-title":"EuroClonality\/BIOMED-2 guidelines for interpretation and reporting of Ig\/TCR clonality testing in suspected lymphoproliferation","volume":"26","author":"Langerak","year":"2012","journal-title":"Leukemia."},{"issue":"9","key":"2023110721241376800_CIT0035","first-page":"399","article-title":"Plasmablastic lymphoma","volume":"147","author":"Fern\u00e1ndez-\u00c1lvarez","year":"2016","journal-title":"Med Cl\u00edn (Engl Ed)"}],"container-title":["Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/labmed\/article-pdf\/54\/6\/e177\/52799373\/lmad060.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/labmed\/article-pdf\/54\/6\/e177\/52799373\/lmad060.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T21:25:06Z","timestamp":1699392306000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/labmed\/article\/54\/6\/e177\/7224274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,14]]},"references-count":35,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,7,14]]},"published-print":{"date-parts":[[2023,11,2]]}},"URL":"https:\/\/doi.org\/10.1093\/labmed\/lmad060","relation":{},"ISSN":["0007-5027","1943-7730"],"issn-type":[{"value":"0007-5027","type":"print"},{"value":"1943-7730","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,11,1]]},"published":{"date-parts":[[2023,7,14]]}}}